SEGMENT REPORTING |
14. SEGMENT REPORTING
The
Company’s Chief Executive Officer and Executive Chairman jointly serve as the Chief Operating Decision Maker (“CODM”),
organize the Company, manage resource allocations and measure performance among two operating and reportable segments: (i) Healthcare
IT and (ii) Medical Practice Management.
The
Healthcare IT segment includes revenue cycle management, SaaS solutions and other services. The Medical Practice Management segment includes
the management of three medical practices. Each segment is considered a reporting unit. The CODM evaluates the financial performance
of the business units on the basis of revenue and direct operating costs excluding unallocated amounts that are mainly corporate overhead
costs. Our CODM does not evaluate operating segments using asset or liability information. The accounting policies of the segments are
the same as those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC
on March 21, 2024. The following table presents revenues, operating expenses and operating income (loss) by reportable segment:
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
|
|
Healthcare IT |
|
|
Medical
Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
|
|
Three Months Ended March 31, 2024 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical
Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
Net revenue |
|
$ |
22,721 |
|
|
$ |
3,241 |
|
|
$ |
- |
|
|
$ |
25,962 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
12,544 |
|
|
|
2,633 |
|
|
|
- |
|
|
|
15,177 |
|
Selling and marketing |
|
|
1,760 |
|
|
|
10 |
|
|
|
- |
|
|
|
1,770 |
|
General and administrative |
|
|
2,581 |
|
|
|
434 |
|
|
|
706 |
|
|
|
3,721 |
|
Research and development |
|
|
913 |
|
|
|
- |
|
|
|
- |
|
|
|
913 |
|
Depreciation and amortization |
|
|
3,845 |
|
|
|
85 |
|
|
|
- |
|
|
|
3,930 |
|
Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
322 |
|
|
|
- |
|
|
|
- |
|
|
|
322 |
|
Net loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
322 |
|
|
|
- |
|
|
|
- |
|
|
|
322 |
|
Total operating expenses |
|
|
21,965 |
|
|
|
3,162 |
|
|
|
706 |
|
|
|
25,833 |
|
Operating income (loss) |
|
$ |
756 |
|
|
$ |
79 |
|
|
$ |
(706 |
) |
|
$ |
129 |
|
|
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
|
|
Three Months Ended March 31, 2023 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
Net revenue |
|
$ |
26,954 |
|
|
$ |
3,047 |
|
|
$ |
- |
|
|
$ |
30,001 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
15,693 |
|
|
|
2,414 |
|
|
|
- |
|
|
|
18,107 |
|
Selling and marketing |
|
|
2,604 |
|
|
|
8 |
|
|
|
- |
|
|
|
2,612 |
|
General and administrative |
|
|
2,496 |
|
|
|
448 |
|
|
|
2,176 |
|
|
|
5,120 |
|
Research and development |
|
|
1,078 |
|
|
|
- |
|
|
|
- |
|
|
|
1,078 |
|
Depreciation and amortization |
|
|
2,949 |
|
|
|
89 |
|
|
|
- |
|
|
|
3,038 |
|
Net loss on lease terminations and unoccupied lease charges |
|
|
269 |
|
|
|
- |
|
|
|
- |
|
|
|
269 |
|
Net loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
269 |
|
|
|
- |
|
|
|
- |
|
|
|
269 |
|
Total operating expenses |
|
|
25,089 |
|
|
|
2,959 |
|
|
|
2,176 |
|
|
|
30,224 |
|
Operating income (loss) |
|
$ |
1,865 |
|
|
$ |
88 |
|
|
$ |
(2,176 |
) |
|
$ |
(223 |
) |
|